SLIDE 1 The international collaborative project to evaluate the availability and accessibility of
- pioids for the management of cancer pain in
Africa, Asia, Latin America and Middle East Preliminary results for peer review:
ASIA
Nathan I Cherny
Project coordinator
Chair, ESMO Palliative Care Working Group Member, EAPC research steering committee Norman Levan Chair in Humanistic Medicine Dept Oncology Unit Head: Cancer pain and palliative Medicine Shaare Zedek Medical Center, Jerusalem, Israel Chernyn@Netvision.net.il
SLIDE 2
General Background Data
SLIDE 3
Asia General
SLIDE 4 Formulary and Cost 7 essential opioids
Codeine Morphine, Oral Immediate Release (MoIR) Morphine, Oral Controlled Release (MoCR) Morphine, injectable (MoINJ) Oxycodone, Oral Immediate Release (OcIR) Methadone, Oral (MoPO) Fentanyl, transdermal patch (FentTD)
SLIDE 5
Formulary and Cost: Asia
SLIDE 6
Actual Availability 7 essential opioids
SLIDE 7
Actual Availability: Asia
SLIDE 8
Eligibility Restrictions (Patient permits)
SLIDE 9
Eligibility Restrictions : Asia
SLIDE 10
Restrictions of prescribing authority
SLIDE 11
Prescription Privileges: Asia
SLIDE 12
Prescription restriction: Number of days supply that can be prescribed
SLIDE 13
Days allowed/prescription: Asia
SLIDE 14
Restrictions on “As needed” (PRN) prescribing
SLIDE 15 Asia: PRN prescriptions
Allowed Not Allowed
SLIDE 16
Prescription restriction:
Increased bureaucratic burden with multiple copies or special forms
SLIDE 17
Prescription forms: Asia
SLIDE 18
Pharmacist restrictions
SLIDE 19
Pharmacist Restrictions: Asia
SLIDE 20
Dispensing restrictions
SLIDE 21
Dispensing: Asia
SLIDE 22
Negative laws regarding medical use of opioids
SLIDE 23
Laws: Asia
